Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by Crossref.
Rodriguez-Rojas, Rafael
Machado, Calixto
Álvarez, Lázaro
Carballo, Maylen
Estevez, Mario
Perez-Nellar, Jesus
Pavon, Nancy
Chinchilla, Mauricio
Carrick, Frederick R.
and
DeFina, Philip
2013.
Zolpidem induces paradoxical metabolic and vascular changes in a patient with PVS.
Brain Injury,
Vol. 27,
Issue. 11,
p.
1320.
Leonardi, Matilde
Sattin, Davide
and
Raggi, Alberto
2013.
An Italian population study on 600 persons in vegetative state and minimally conscious state.
Brain Injury,
Vol. 27,
Issue. 4,
p.
473.
Appu, Merveen
and
Noetzel, Michael
2014.
Clinically Significant Response to Zolpidem in Disorders of Consciousness Secondary to Anti-N-Methyl-d-Aspartate Receptor Encephalitis in a Teenager: A Case Report.
Pediatric Neurology,
Vol. 50,
Issue. 3,
p.
262.
Becker, Philip M.
and
Somiah, Manya
2015.
Non–Benzodiazepine Receptor Agonists for Insomnia.
Sleep Medicine Clinics,
Vol. 10,
Issue. 1,
p.
57.
Brown, Ritchie E.
and
McKenna, James T.
2015.
Turning a Negative into a Positive: Ascending GABAergic Control of Cortical Activation and Arousal.
Frontiers in Neurology,
Vol. 6,
Issue. ,
Tucker, Calvin
and
Sandhu, Kirsten
2016.
The Effectiveness of Zolpidem for the Treatment of Disorders of Consciousness.
Neurocritical Care,
Vol. 24,
Issue. 3,
p.
488.
Gosseries, Olivia
Pistoia, Francesca
Charland-Verville, Vanessa
Carolei, Antonio
Sacco, Simona
and
Laureys, Steven
2016.
The Role of Neuroimaging Techniques in Establishing Diagnosis, Prognosis and Therapy in Disorders of Consciousness.
The Open Neuroimaging Journal,
Vol. 10,
Issue. 1,
p.
52.
Estévez, Mario
Machado, Calixto
Leisman, Gerry
Estévez-Hernández, Talía
Arias-Morales, Asdrúbal
Machado, Andrés
and
Montes-Brown, Julio
2016.
Spectral analysis of heart rate variability.
International Journal on Disability and Human Development,
Vol. 15,
Issue. 1,
Daniele, Antonio
Panza, Francesco
Greco, Antonio
Logroscino, Giancarlo
and
Seripa, Davide
2016.
Can a Positive Allosteric Modulation of GABAergic Receptors Improve Motor Symptoms in Patients with Parkinson’s Disease? The Potential Role of Zolpidem in the Treatment of Parkinson’s Disease.
Parkinson's Disease,
Vol. 2016,
Issue. ,
p.
1.
Noormandi, Afsaneh
Shahrokhi, Maryam
and
Khalili, Hossein
2017.
Potential benefits of zolpidem in disorders of consciousness.
Expert Review of Clinical Pharmacology,
Vol. 10,
Issue. 9,
p.
983.
Sutton, J. A.
and
Clauss, R. P.
2017.
A review of the evidence of zolpidem efficacy in neurological disability after brain damage due to stroke, trauma and hypoxia: A justification of further clinical trials.
Brain Injury,
Vol. 31,
Issue. 8,
p.
1019.
Machado, Calixto
Estévez, Mario
and
Rodriguez-Rojas, Rafael
2018.
Zolpidem efficacy and safety in disorders of consciousness.
Brain Injury,
Vol. 32,
Issue. 4,
p.
530.
Gosseries, Olivia
and
Whyte, John
2018.
Coma and Disorders of Consciousness.
p.
181.
Estévez-Báez, Mario
Machado, Calixto
Montes-Brown, Julio
Jas-García, Javier
Leisman, Gerry
Schiavi, Adam
Machado-García, Andrés
Carricarte-Naranjo, Claudia
and
Carmeli, Eli
2018.
Progress in Medical Research.
Vol. 1070,
Issue. ,
p.
49.
Machado, Calixto
2021.
Jahi McMath, a New Disorder of Consciousness.
Revista Latinoamericana de Bioética,
Vol. 21,
Issue. 1,
p.
137.
Morris, Brittan
and
Wong, John
2022.
A scoping review of treatments for the vegetative and minimally conscious states.
Brain Network and Modulation,
Vol. 1,
Issue. 2,
p.
57.
Szymkowicz, E.
Alnagger, N.
Seyfzadehdarabad, F.
Cardone, P.
Whyte, J.
and
Gosseries, O.
2023.
Coma and Disorders of Consciousness.
p.
115.